Presentation is loading. Please wait.

Presentation is loading. Please wait.

71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice  Mari Hirvinen,

Published byOuti Koskinen Modified over 5 years ago

Similar presentations

Presentation on theme: "71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice  Mari Hirvinen,"— Presentation transcript:

1 71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice  Mari Hirvinen, Cristian Capasso, Kilian Guse, Mariangela Garofalo, Andrea Vitale, Marko Ahonen, Lukasz Kuryk, Markus Vähä-Koskela, Akseli Hemminki, Dario Greco, Vincenzo Cerullo  Molecular Therapy  Volume 23, (May 2015) DOI: /S (16) Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions

2 Molecular Therapy 2015 23, DOI: (10.1016/S1525-0016(16)33676-0)
Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions

Download ppt "71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice  Mari Hirvinen,"

Similar presentations

Volume 19, Issue 9, Pages (September 2011)

Volume 19, Issue 9, Pages (September 2011)
Molecular Therapy - Oncolytics

Molecular Therapy - Oncolytics
Molecular Therapy - Oncolytics

Molecular Therapy - Oncolytics
Volume 23, Issue 5, Pages (May 2015)

Volume 23, Issue 5, Pages (May 2015)
Molecular Therapy - Oncolytics

Molecular Therapy - Oncolytics
Volume 18, Issue 10, Pages (October 2010)

Volume 18, Issue 10, Pages (October 2010)
Volume 24, Issue 7, Pages (July 2016)

Volume 24, Issue 7, Pages (July 2016)
Volume 20, Issue 2, (February 2012)

Volume 20, Issue 2, (February 2012)
414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 
209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.
446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,
627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.
Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Volume 15, Issue 12, Pages (December 2007)

Volume 15, Issue 12, Pages (December 2007)
Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Volume 24, Issue 1, Pages (January 2016)

Volume 24, Issue 1, Pages (January 2016)
Evolving Gene Therapy in Primary Immunodeficiency

Evolving Gene Therapy in Primary Immunodeficiency

Similar presentations

Ads by Google